| Serial Number | 98330228 |
| Word Mark | CENCORA |
| Filing Date | Tuesday, December 26, 2023 |
| Status | 661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED |
| Status Date | Thursday, August 29, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 5 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
| Published for Opposition Date | NOT AVAILABLE |
| Description of Mark | The mark consists of the stylized word "CENCORA". |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Goods and Services | Outsource service provider in the field of business management for companies engaged in the field of medicine development, authorization, production, sale, safety and monitoring; Consumer research services in the field of drug safety; Business management services in the field of clinical trials, namely, compilation and management of regulatory submission data on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; Business consulting services in the field of medical clinical trials management; assistance and consultancy in the field of business management in relation to automation of content compilation and document dossier development and automation for creation of documents for achieving medical marketing authorization and marketing approval, all of the foregoing provided to companies engaged in medicine and medical device authorization and lifecycle maintenance; regulatory submission management, namely, assisting others in filing of documents with regulatory authorities for authorizing and lifecycle maintenance of medicines and medical devices using documents, reports and files required by regulatory authorities via automation of content compilation and document dossier development, automation for creation of documents for achieving medical marketing authorization and marketing approval with government regulatory bodies; Acquisition and merger consultation; Advertising, management of business for others, business administration; business efficiency expert services; systemization of information into computer databases; compilation of information into computer databases; business support and advice in the field of drug distribution in retail and wholesale stores for advertising purposes; providing outsourced office functions services for drug approval, manufacturing, distribution, supply chain security and safety monitoring; assistance and consultancy in the field of distributing medicines for advertising purposes via retail and wholesale stores; business consultancy services in the fields of controlling and managing business information and implementing and managing databases |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, December 26, 2023 |
| Primary Code | 035 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Cencora, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Conshohocken, PA 19428 |
| Event Date | Event Description |
| Tuesday, December 26, 2023 | NEW APPLICATION ENTERED |
| Monday, April 8, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, May 28, 2024 | ASSIGNED TO EXAMINER |
| Wednesday, June 5, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, June 5, 2024 | NON-FINAL ACTION E-MAILED |
| Wednesday, June 5, 2024 | NON-FINAL ACTION WRITTEN |
| Thursday, August 29, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, August 29, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, August 29, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |